Cardiovascular diseases (CVDs) are the most abundant causative factors of mortality and morbidity in the world specifically in the developing countries. Statistics show that approximately 17.3 million people die every year due to CVDs, equivalent to 30% of all deaths all over the world. Developing countries recently share with more than 80% of all CVD deaths. Atherosclerosis is the main cause of CVDs that include myocardial infarction, heart failure, stroke and peripheral artery disease. Many studies on humans and animals prove that inflammation plays a key role in the initiation and propagation of the process of atherosclerosis. Coronary artery disease (CAD) as a type of atherosclerotic diseases, are recognized to be chronic inflammatory diseases. Interleukin-27 (IL-27) is a new IL-12/IL-6 family member which is a heterodimeric multifunctional pro-and anti-inflammatory cytokine. IL-27 constituted by an IL-27p28 subunit linked to Epstein-Barr virus (EBV)-induced gene3 product (EBI3) subunit. IL-27 one of the important cytokines distinguished in atherosclerotic plaques. Unlike other members of cytokine family IL-27 has dual function, one as an initiator and the other as an attenuator of immune/inflammatory responses. Many studies ascertain the concept that elevated IL-27 may be one of the main cytokines that constitute a regulatory network in immunity and inflammation that affect atherosclerosis. In this review we focus on the coronary artery atherosclerosis its etiology, risk factors and consequences such as myocardial infarction and sudden cardiac death. The pathogenesis of atherosclerosis that include: lipoproteins accumulation, recruitment of immune cells and development of foam cells. Define atherosclerosis as an inflammatory process and the contribution of inflammatory mediators such as TNF-α, IL-6 and IFN-γ in its initiation and progression.IL-27 its construction, production,IL-27 receptors and signaling pathway, the pro and anti-inflammatory characters of IL-27 via T helper1 (Th1), T helper2 (Th2) and IL-10.Finally the effect of IL-27 as an inflammatory regulator in the process of atherogenesis.
Introduction
Cardiovascular diseases (CVDs) are classified as foremost causative factors of mortality in the world specifically in the developing countries. Coronary artery disease (CAD), precisely atherosclerotic CAD is the major CVD primarily triggered by atherosclerosis. CAD is a multifactorial disease that several environmental and genetic risk factors contribute to its pathogenesis [1] . Inflammation contributes significantly in the initiation and progression of atherosclerosis [2] . Numerous studies suggest that atherosclerosis may be considered as an immune-mediated chronic inflammatory disease [3] . Studies on humans and animals prove vital role of macrophage and T cell infiltrates in the atherosclerotic lesions [4] . Interleukin 27 (IL-27) is a new and important IL-12 family member recovered primarily from Epstein-Barr virus (EBV)-induced transformed B cell lines, which is a heterodimeric multifunctional pro-and anti-inflammatory cytokine. IL-27 is constituted by an IL-27p28 linked to EBV-induced gene3 product (EBI3) subunit [5] (Figure 1) . The human IL-27 gene is positioned on chromosome 16p11 and consisted of five exons. This gene is vital for the growth and differentiation of T cells [6] . IL-27 is an immune/inflammatory response regulator with antiinflammatory character that modulates T cell polarization and production of cytokines by indorsing early T helper 1 (Th1) differentiation and repressing both Th2 and Th17 differentiation [7, 8] . Expression of IL-27 has been also noted in atherosclerotic plaques [9] . During the initiation and progression of atherosclerosis, IL-27 imparts its effect on macrophage as well as T cell functions. As such, the expressed IL-27 in the arterial wall appears not only to regulate macrophage activities, such as phagocytosis and other consecutive cytokine production, but also have crucial impact on other immune and non-immune cells types through controlling the production of cytokines [10] . In this review, the pathogenesis of atherosclerosis and the effect of IL-27 as an inflammatory mediator in the process of atherogenesis will be discussed.
Coronary artery atherosclerosis
Atherosclerosis can be defined as progressive disorder characterized by low-grade inflammation of the of mediumsized arterial intima (inward lining of the artery) that is augmented by risk factors such as diabetes, hypertension (HTN), dyslipidemia, smoking, and genetic factors. Considering coronary atherosclerosis, this slow progression result in gradual
increase in the stiffening of the inner layer of the coronary arteries that on the long run causes narrowing of the arterial lumen to different degrees. Atherosclerosis is the leading cause of coronary syndrome of acute myocardial infarction(AMI) and sudden cardiac death(SCD) [11] . AMI is described as acute disturbance between myocardial blood supply and myocardial oxygen demand leading to myocardial necrosis based on clinical evidences that consistent with the diagnosis. These evidences comprise the presenting features of the patient, the finding of the electrocardiograph (ECG), and/or other indication signifying a recent wall motion abnormality in the segments of the myocardium that assessed by the echocardiography [12] . SCD explains the unpredicted natural death that is triggered by a cardiac cause over a period of very short time, mostly not exceeds one hour from starting the onset of complain, in a person that is free from any previous condition that seems to be fatal. SCD is typically subsequent to a catastrophic cardiac arrhythmia like ventricular fibrillation (VF), which is a common consequence of the acute coronary artery thrombosis that reduces cardiac arrhythmia threshold [13] .
Pathogenesis of atherosclerosis

Lipoproteins Accumulation
Buildup of low-density lipoprotein (LDL) in the intima of the arteries is the key step for establishment of atherosclerosis. The retaining of the invading LDL particles on subendothelial proteoglycans is the starting incident in the initiation of atherosclerosis [14] . Proteases and lipases modify the entrapped lipoproteins particles triggering their aggregation thus increasing binding of proteoglycan [15] . Myeloperoxidase, lipoxygenase, and reactive oxygen species induce oxidative modifications which subsequently result in the formation of oxidized form of LDL (ox LDL), which can provoke an innate inflammatory response [16] .
Recruitment of immune cells
Endothelial cells respond to the cumulative effects of the entrapped and modified lipoproteins in the subendothelial space by expressing adhesion protein, like vascular cell adhesion molecule-1 (VCAM-1) [17] . Leukocytes are then recruited to the affected sites. Granulocyte-macrophage colony stimulating factor and macrophage colony-stimulating factor both play crucial role in the differentiation of the invading monocytes into macrophages. Both factors are formed by the endothelium and other numerous cell types. The advanced imaging techniques allowed following the leukocyte migration on the surface of the endothelium in atherosclerotic plaques in live mice [18] . In atherosclerotic plaques, macrophages derived from monocyte remain the foremost cell population due to their continuous local enrollment, differentiation, and proliferation [19] .
Development of Foam cells
Macrophages are transformed in to foam cells as a consequence of the unceasing engulfment of lipoprotein particles [20] . Scavenger receptors are expressed by macrophages, among these expressed receptors are CD36 and class A scavenger receptors that have significant role in modified LDL uptake [21] . Unlike LDL receptors, scavenger receptors are not downregulated responding to intracellular cholesterol. The other pathway for lipid uptake by macrophages is through pinocytosis [22] . The entrapped foam cells inside the arterial intima compromise the blood flow and migratory capacity of the artery. Eventually these cells die then generate a core in the plaque area composed of necrotic, apoptotic cells, cholesterol crystals and other extracellular material [23] .
Inflammation and Atherosclerosis
In the middle of the 19 th century, Virchow and von Rokitansky established for the first time the contribution of inflammation to the process of atherosclerosis and reported that atherosclerotic vessels have evidence of cellular inflammation. Subsequently, this concept was extended by Ross and Glomset, who prove that infiltration of the subendothelial layer of the arterial wall by monocyte and macrophage was an initial step of atherosclerosis [24] . Several soluble mediators of the inflammatory response have been suggested to predict cardiovascular risk in patients with atherosclerosis [25] . Following the atherosclerotic progression allows establishment of various evidences that suggest atherosclerosis results from micro inflammation induced by pro-inflammatory cytokines. The evidence that detection of T lymphocytes and monocytes were at all stages of atherosclerotic plaque progression, is consistent with active inflammation in animal models. In addition, marked increase in circulating blood levels of the acute phase reactant like Creactive protein (CRP) is suggested to be a marker of inflammatory processes and may be of value in the prediction of acute coronary artery events [26] .The LDL-induced inflammatory response of endothelial cells and LDL accumulation in the intima are believed to be involved in the initiation of atherosclerosis [27] . Previous studies prove that circulating levels of IL-27 were markedly overstated in patients with CAD, and significantly correlated to ox-LDLox-LDL dose- dependently up regulated expression of both IL-27 protein and IL-27 (p28 and EBI3) mRNA in vitro, specifying that ox-LDL capable of endorsing production of IL-27 by dendritic cells (DCs). These findings suggested that IL-27 can modulate the network of immunity and inflammation in the pathogenesis of atherosclerosis [28] . Previous studies identified variety of proinflammatory cytokines, such as tumor necrosis factor-α (TNF-α), IL-17, IL-6, IL-12, and interferon-γ (IFN-γ), as vital key regulators of atherosclerosis development and progression [29] .
The recent literatures buildup a growing body of evidence that support the relationship between various inflammatory biomarkers and potential cardiovascular risk, in healthy individuals as well as in patients with coronary heart disease or heart failure [30] . Activated T cells are differentiated into Th1 effector cells and start to produce the macrophage-activating cytokine INF-γ, which improves the efficiency of antigen presentation and potentiate the synthesis of inflammatory cytokines such as TNF-α and IL-1 [31] . These cytokines work synergistically to promote the production of many inflammatory and cytotoxic molecules in macrophages and vascular cells [27] .
The process of inflammation in atherosclerosis may lead to elevated blood levels of inflammatory cytokines and other acute-phase reactants such as level of CRP and IL-6,which are markedly elevated in patients presented with unstable angina and acute myocardial infarction, as well as elevated level indicating bad prognosis [32] . Other inflammatory markers are also elevated in those patients, including fibrinogen, IL-7, IL-8, and the CRP-related protein pentraxin-3Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease [33] . The elevated levels of CRP in patients with unstable angina, a condition that is essentially relies on coronary thrombosis of atherosclerotic plaques, can be used as a method for differentiation from those with vasospastic angina. Consequently, elevated level of CRP in patients with acute coronary syndromes expectedly reflects inflammation in the coronary artery rather than other causes of ischemic myocardium [34] . Endothelial cells express adhesion molecules and secrete several chemokines that lead to the recall of inflammatory cells that participate in the sub-endothelial inflammation. Accumulating monocytes are differentiated into plaque macrophages that take up accumulated LDL-cholesterol forming foam cells [35] , these foam cells by the effect of inflammatory cytokines acquire typically activated proinflammatory (M1) phenotype that subsequently promote inflammation. Consequently, the formation of primary atherosclerotic plaques is initiated [36] . Once plaque inflammation initiated, there are two consequences, the first is the direction of downregulation in the initial inflammatory reaction with healing and fibrotic processes that resulting in plaque stabilization by the formation of a thick, stable fibrous cap. The second is for vulnerable plaque followed by life threatening consequences, such as stroke and myocardial infarction. In the later, chronic inflammation is accelerated, the plaque becomes unstable, and the fibrous cap becomes thin all of them result in plaque rupture that is complicated by rapid lumen closure with thrombus burden and subsequently an acute clinical event. Such highly unstable plaque is characterized by active chronic inflammatory reactions that include constant infiltration of inflammatory cells and the production of inflammatory cytokines [37] .
IL-27
IL-27 is a heterodimeric cytokine and due to its structural characteristics and common receptors IL-27 related to the superfamily IL-6/IL-12 cytokines. IL-27 constructed of two functional subunits p28 (IL-27a) and EBI3 (Epstein-Barr virusinduced gene 3) (IL-27b) [6] . like most of the IL-6-family members, the alpha-subunit p28 of IL-27 is a four-helical bundle, while EBI3 is the soluble form of alpha receptor that composed of two fibronectin-like domains [38] . Antigenpresenting cells are mainly responsible for production of IL27p28 and EBI3 consequent to stimulation by inflammatory mediators or microbial products [6] . Myeloid lineage cells primarily monocytes and activated dendritic cell are the main source of p28 and EBI3 [6] . The signal of IL-27 is conducted through receptor complex that is constituted by Glycoprotien130 (gp130) and WSX-1 forming a heterodimer on the surface of the cell that mostly stimulates the Janus kinases (Jak)/signal transducer and activator of transcription (STAT) (Figure 1) . Unlike the pro-inflammatory properties of IL-6 via gp130 receptor, IL-27 was primarily stated as immunoregulatory mediator. This was mainly depending on the concept that IL-27 stimulates IL-10 secretion as well as confines inflammatory responses in the area of infection [39] .
IL-27 receptors
IL-27 exerts its action through binding to heterodimeric membrane-bound receptor complex consists mainly of the two distinct subunits the first is gp130, which has predominant expression and considered the leading signal transducing betareceptor utilized by most IL-6 and IL-12 family members, the second is IL-27R alpha (WSX-1) also called (T cell cytokine receptor, (TCCR)) which imparts ligand specificity and has limited recognized functions other than IL-27 signaling. IL-27ra (WSX-1) is a type I trans-membrane protein receptor which stimulates the Jak/STAT signaling pathway once receptor complex is formed upon ligand binding. Naïve CD4+ T cells show low levels of expression of IL-27ra (WSX-1) while higher levels of expression are noticed on effector and memory T cells that make them the central targets for IL-27 action [40] . IL-27 can bind to IL-27ra (WSX-1) even if gp130 is absent [41] . Nevertheless, for signal transduction to occur the co-expression of both subunits of the receptor is essential [42] . Not only T cells can expressIL-27 receptor complex but also innate immune cells, like macrophages, endothelial cells and dendritic cells share its expression, which demonstrating that several types of cells can respond to IL-27 signaling [43] . Because of soluble gp130 has not competence to inhibit IL-27 signaling, IL-27 cannot solely bind to gp130 receptor [44] . gp130 expression analysis is not reliably informative as indicator for the signaling pattern of IL-27 because the gp130 chain is widely expressed.
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Consequently, IL-27 sensitivity is frequently evaluated by studying expression level of IL-27ra (WSX-1), which is restricted largely to the immune system even if the expression levels in other tissues is low [45] . gp130 mainly stimulates STAT3, while WSX-1 stimulates STAT1, that consequently lead to a diversity of signaling actions, like T-bet-induced induction of IL-12 receptor β chain (Il12rb2), in addition to induction of pro-inflammatory IFN-γ and anti-inflammatory IL-10 [43] (Figure 1). 
IL-27 as pro-and anti-inflammatory cytokine
Primarily IL-27 was discovered and specified as a type of cytokine with pro-inflammatory character that induces T helper 1 (Th1) differentiation primary during immune responses [6] . T helper cells are the uppermost antigen recognizing and classified functionally into two distinct subtypes identified as Th1 and Th2. Th1 responds by the amplification of proinflammatory pathways through secretion of cytokines such as IFN-γ, so the Th1 response mostly to exacerbate atherosclerosis. Recent studies recognized other T cell subset Th17 cells, also may have predominant pro-inflammatory activities [46] . While IL-27 stimulates Th1 transcription factors (T-bet) as well as (STAT-1) in addition to the up-regulation of the expression of the IL-12Rβ2 chain, EBI3 (Ebi3 _ / _ ) or IL-27Rβ (Il27ra _ / _ ) deficient mice did not exhibit marked deficiency in the capability to mount Th1 responses, even Th1 responses are delayed in a limited number of infection [46] .Subsequent studies revealed that binding of IL-27 to IL-27 receptor and complex formation led to the phosphorylation of signal transducer and activator of transcription (STAT-1) in naïve CD4+ T cells, triggering them to proliferate and become polarized Th1 cells [43] . Consequently, complete response of Th1 is essential to regulate intracellular infection by protozoa. IL-27 signaling deficient mice experienced with protozoal infection were predicted to have a diminished Th1 response. Unexpectedly, Mice deficient with one subunit of the receptor IL-27Ra (WSX-1 -/-) encountered with parasitic protozoa had intact Th1 responses, developed excessive pathological inflammation yet capitulated to CD4+ T cell-mediated immunepathology, signifying the essential role of IL-27 to control in vivo inflammation [39] . Furthermore, Successive studies on several infectious and autoimmune disease models established the anti-inflammatory role for IL-27 in Th1, Th2, and Th17 responses [43] , regarding the anti-inflammatory effects of IL-27, current efforts have revealed that IL-27 can trigger the production of the anti-inflammatory cytokine IL-10 by T cells [47] . IL-27 represses the immunologic pro-inflammatory responses of IL-17 producing Th17 cells in various experimental animal models, such as animal model of autoimmune encephalomyelitis (EAE), neurological disease characterized by demyelination and autoimmune inflammation of the central nervous system and human multiple sclerosis model [48] . Several studies find significant relation between the elevated serum levels of IL-27 and other interleukins such as IL-10, IL-17A, IL-6 and TNF-α in inflammatory disease such as asthma, rheumatoid arthritis and Kawasaki disease (KD)
providing further evidence about the inflammatory role of IL-27 in KD, These explanations specify that IL-27 play an essential role in the immunity and inflammation response [49] . Therefore, while IL-27 was initially categorized as a proinflammatory cytokine, successive studies have concentrated on its anti-inflammatory effects.
IL-27, Atherosclerosis and coronary artery disease
IL-27 is a crucial member of cytokines in the inflammatory diseases, specifically CAD [1] . Numerous studies advocate the influential function of Interleukin-27 in the development and progression of atherosclerosis [50] . Atherosclerosis is considered as chronic multifactorial vascular disease diffused by inflammatory mediators, like cytokines, chemokines and other mediators [51] . Inflammatory cytokines produced by immune and vascular cells with pro-and anti-inflammatory properties contribute significantly in the initiation and progression of atherosclerosis via controlling cellular signaling in arterial wall via paracrine and autocrine manner [52] . Previous studies presented numerous pro-inflammatory cytokines, such as TNF-α, IL-6, IL-12, IL-17 and IFN-γ, as key regulators in the developing and progression of atherosclerosis [53] . Nonetheless, studying the anti-inflammatory activity of these mediators as negative inflammatory regulators is limited. Recently, studies have recognized that differentiation of macrophages produces several subsets of cells including M1 macrophage phenotype, subsets stimulated by IFN-mediated Th1 type response and M2 macrophage phenotype, subsets stimulated by Th2 response [54] . Each subset signifies discriminated impact as inflammatory regulators in processes of inflammation and atherogenesis [55] . M1 macrophages impart pro-inflammatory functions via Th1 response augmentation and elevated production of pro-inflammatory IL-12 and reduced anti-inflammatory IL-10 production. In contrary, M2 macrophages exhibit immunoregulatory functions via phagocytosis Th2 response promotion, and elevated antiinflammatory IL-10 production. Augmented production of IFNvia IL-27-and IL-27 receptor-deficient macrophages has been demonstrated, signifying that IL-27 impairs macrophage cellautonomous activation and M1 polarization via regulating IFN secretion not only in paracrine but also in autocrine manner [47] . IL-27 significantly improved recovery of post-ischemic and attenuate tissue damage of isolated perfused hearts upon administration five minute earlier to reperfusion. This finding points to that IL-27 has protective role in the myocardium against ischemia/reperfusion (IR) injury and enhance cardiomyocytes recovery via the gp130/STAT3pathway [56] . IL-27 modulates pathological microenvironment in walls of the arteries that controls atherogenesis via regulation of cytokine induced macrophage production. The activation of macrophage in the arterial wall is a crucial step in atherosclerotic plaque rupture and this process induces thrombotic occlusion in the coronary arteries and consequent acute coronary syndrome.
Immunosuppressive cytokines have vital role in local arterial lesions through immunoregulation which is beneficial to halt atherosclerosis and other interrelated diseases [57] . IL-27 solely
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can considerably endorse the release of Interferon gammainduced protein 10 (CXCL10) cytokine. Furthermore IL-27 can markedly augment the up regulation of TNF-α-mediated intercellular adhesion molecules (ICAM-1), vascular cell adhesion protein-1(VCAM-1), inflammatory cytokine IL-6 from the endothelial cells of human coronary arteries. The release of IL-6 and CXCL10 were markedly repressed by particular signaling molecule inhibitors [58] . Therefore, these findings signify the anti-inflammatory function of IL-27 that made it candidate for utilization in the treatment and prevention of atherosclerosis.
